Deals
Hedge Fund Sees 21% Returns on Advice From Nobel Prize Pickers
- Rhenman holds about 140 positions, including Shire, Horizon
- Fund has rallied in 2017 on outlook for more industry mergers
This article is for subscribers only.
If you’re investing in health care stocks, you’d better ask the experts.
Thanks to the advice from a range of professors, Swedish hedge fund Rhenman Healthcare Equity L/S has delivered an average annual return of 21 percent since it started in 2009. Asking clinical expertise before investing in complex products is a must for Henrik Rhenman, who manages the 460 million-euro ($500 million) fund.